These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33775525)

  • 1. Standardization, workforce development and advocacy in cell and gene therapies: a summary of the 2020 Regenerative Medicine InterCHANGE.
    McNiece IK; Wacker KK; Kurtzberg J; Warkentin PI
    Cytotherapy; 2021 Oct; 23(10):886-893. PubMed ID: 33775525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Filling the gap: the workforce of tomorrow for CGT manufacturing as the sector advances.
    Hopewell E; Pike NR; Lembong J; Hewitt M; Fekete N
    Cytotherapy; 2024 Jun; 26(6):540-545. PubMed ID: 38573277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manufacturing road map for tissue engineering and regenerative medicine technologies.
    Hunsberger J; Harrysson O; Shirwaiker R; Starly B; Wysk R; Cohen P; Allickson J; Yoo J; Atala A
    Stem Cells Transl Med; 2015 Feb; 4(2):130-5. PubMed ID: 25575525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steady advance of stem cell therapies: report from the 2011 World Stem Cell Summit, Pasadena, California, October 3-5.
    Swan M
    Rejuvenation Res; 2011 Dec; 14(6):699-704. PubMed ID: 22175514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standards efforts and landscape for rapid microbial testing methodologies in regenerative medicine.
    Lin-Gibson S; Lin NJ; Jackson S; Viswanathan S; Zylberberg C; Wolfrum J; Basu S; Roy K; Marshall D; McFarland R; Hoover S; Rietze R; Getz A; Henke D
    Cytotherapy; 2021 May; 23(5):390-398. PubMed ID: 33775524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA and NIST collaboration on standards development activities supporting innovation and translation of regenerative medicine products.
    Arcidiacono JA; Bauer SR; Kaplan DS; Allocca CM; Sarkar S; Lin-Gibson S
    Cytotherapy; 2018 Jun; 20(6):779-784. PubMed ID: 29784433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging workforce readiness in regenerative healthcare.
    Wyles SP; Monie DD; Paradise CR; Meyer FB; Hayden RE; Terzic A
    Regen Med; 2021 Mar; 16(3):197-206. PubMed ID: 33622054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational strategies and challenges in regenerative medicine.
    Dimmeler S; Ding S; Rando TA; Trounson A
    Nat Med; 2014 Aug; 20(8):814-21. PubMed ID: 25100527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current status of the regulation and development of cell therapy products in Japan].
    Igarashi Y; Sato Y
    Nihon Yakurigaku Zasshi; 2018; 151(6):254-259. PubMed ID: 29887575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial intelligence: A joint narrative on potential use in pediatric stem and immune cell therapies and regenerative medicine.
    Sniecinski I; Seghatchian J
    Transfus Apher Sci; 2018 Jun; 57(3):422-424. PubMed ID: 29784537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Institutional profile. The International Society for Cellular Therapy: evolving to meet the demands of the regenerative medicine industry.
    Maziarz RT; Arthurs J; Horwitz E
    Regen Med; 2011 Mar; 6(2):163-6. PubMed ID: 21391849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regenerative Medicine: "Are We There Yet?".
    El Haj AJ
    Tissue Eng Part A; 2019 Aug; 25(15-16):1067-1071. PubMed ID: 31115267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on Regulation of Regenerative Medicine in Taiwan.
    Chao WY; Chang YT; Tsai YT; Huang MC; Lin YC; Wu MM; Chi JF; Lin CL; Cheng HF; Wu SM
    Adv Exp Med Biol; 2023; 1430():211-219. PubMed ID: 37526850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interview with Bernard Siegel.
    Siegel B
    Regen Med; 2017 Apr; 12(4):333-335. PubMed ID: 28621178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoting the ethical use of safe and effective cell-based products: the Andalusian plan on regenerative medicine.
    Cuende N; Álvarez-Márquez AJ; Díaz-Aunión C; Castro P; Huet J; Pérez-Villares JM
    Cytotherapy; 2020 Dec; 22(12):712-717. PubMed ID: 32878735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report of the international conference on manufacturing and testing of pluripotent stem cells.
    Abbot S; Agbanyo F; Ahlfors JE; Baghbaderani BA; Bartido S; Bharti K; Burke C; Carlsson B; Cavagnaro J; Creasey A; DiGiusto D; Francissen K; Gaffney A; Goldring C; Gorba T; Griffiths E; Hanatani T; Hayakawa T; Heki T; Hoogendoorn K; Kawamata S; Kimura H; Kirkeby A; Knezevic I; Lebkowski J; Lin S; Lin-Gibson S; Lubiniecki A; O'Shea O; Pera M; Petricciani J; Pigeau G; Ratcliffe A; Sato Y; Schumann GG; Shingleton W; Stacey Chair G; Sullivan S; Svendsen CN; Trouvin JH; Vandeputte J; Yuan BZ; Zoon K
    Biologicals; 2018 Nov; 56():67-83. PubMed ID: 30150108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manufacturing challenges in regenerative medicine.
    Martin I; Simmons PJ; Williams DF
    Sci Transl Med; 2014 Apr; 6(232):232fs16. PubMed ID: 24739757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can we assure quality without stifling innovation?
    Miller L
    Stem Cells Dev; 2014 Dec; 23 Suppl 1(Suppl 1):66-7. PubMed ID: 25457966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the route to medication therapy management documentation and billing standardization and interoperabilility within the health care system: meeting proceedings.
    Millonig MK
    J Am Pharm Assoc (2003); 2009; 49(3):372-82. PubMed ID: 19357067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.